Gene Logic Sells Informatics Business to Ocimum, Pins Future on Drug Repositioning | GenomeWeb
To focus on drug repositioning and development, Gene Logic has sold its genomics arm to India’s Ocimum Biosystems for $10 million.
Founded in 1994 as a bioinformatics firm, Gene Logic has modified its business model several times over the years in response to a steady downturn in the market for gene expression data. The sale of the business represents a final page in this transformation.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.